{
    "2018-01-02": [
        [
            {
                "time": "2018-01-08",
                "original_text": "Lilly to Present at J.P. Morgan Healthcare Conference",
                "features": {
                    "keywords": [
                        "Lilly",
                        "J.P. Morgan",
                        "Healthcare Conference"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2017-10-25",
                "original_text": "Eli Lilly’s Elanco in 3Q17",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Elanco",
                        "3Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "animal health"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2017-10-25",
                "original_text": "Eli Lilly’s Neuroscience Products Portfolio in 3Q17",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Neuroscience",
                        "Products Portfolio",
                        "3Q17"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "neuroscience"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2017-10-25",
                "original_text": "Eli Lilly’s Oncology Products Portfolio in 3Q17",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Oncology",
                        "Products Portfolio",
                        "3Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "oncology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}